Detalhe da pesquisa
1.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
2.
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
MMWR Morb Mortal Wkly Rep
; 73(16): 377-381, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662708
3.
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023.
MMWR Morb Mortal Wkly Rep
; 73(1): 16-23, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206877
4.
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep
; 73(4): 77-83, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300853
5.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep
; 73(12): 271-276, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547037
6.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
MMWR Morb Mortal Wkly Rep
; 73(8): 168-174, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421935
7.
Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period-United States, 1 January 2022 to 31 March 2022.
Clin Infect Dis
; 76(10): 1753-1760, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750643
8.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis
; 76(9): 1615-1625, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611252
9.
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
MMWR Morb Mortal Wkly Rep
; 72(24): 657-662, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319020
10.
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
MMWR Morb Mortal Wkly Rep
; 72(7): 177-182, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795625
11.
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
MMWR Morb Mortal Wkly Rep
; 72(5): 119-124, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730051
12.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
MMWR Morb Mortal Wkly Rep
; 72(42): 1140-1146, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856366
13.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep
; 72(21): 579-588, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227984
14.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
MMWR Morb Mortal Wkly Rep
; 72(33): 886-892, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37590187
15.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921274
16.
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
MMWR Morb Mortal Wkly Rep
; 71(18): 633-637, 2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511708
17.
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
MMWR Morb Mortal Wkly Rep
; 71(45): 1436-1441, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355612
18.
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(48): 1526-1530, 2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454688
19.
Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater - New York, June-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(33): 1065-1068, 2022 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980868
20.
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 416-421, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298454